diabetestalk.net

Neonatal Diabetes Inheritance

Omim Entry - # 606176 - Diabetes Mellitus, Permanent Neonatal; Pndm

Omim Entry - # 606176 - Diabetes Mellitus, Permanent Neonatal; Pndm

A number sign (#) is used with this entry because of evidence that permanent neonatal diabetes mellitus can be caused by homozygous mutation in the glucokinase gene (GCK; 138079 ), by heterozygous mutation in the KCNJ11 ( 600937 ) gene, or by heterozygous or homozygous mutation in the ABCC8 ( 600509 ) and INS ( 176730 ) genes. Pancreatic agenesis, which results in exocrine pancreatic deficiency as well as permanent neonatal-onset diabetes mellitus, can be caused by mutation in the PDX1 gene ( 600733 ). Pancreatic agenesis associated with cerebellar agenesis ( 609069 ) can be caused by mutation in the PTF1A gene ( 607194 ). Pancreatic agenesis associated with congenital cardiac defects ( 600001 ) can be caused by mutation in the GATA6 gene ( 601656 ). Neonatal diabetes mellitus (NDM), defined as insulin-requiring hyperglycemia within the first 3 months of life, is a rare entity, with an estimated incidence of 1 in 400,000 neonates ( Shield, 2000 ). In about half of the neonates, diabetes is transient (see 601410 ) and resolves at a median age of 3 months, whereas the rest have a permanent insulin-dependent form of diabetes (PNDM). In a significant number of patients with transient neonatal diabetes mellitus, type II diabetes (see 125853 ) appears later in life ( Arthur et al., 1997 ). PNDM is distinct from childhood-onset autoimmune diabetes mellitus type I (IDDM; 222100 ). Massa et al. (2005) noted that the diagnostic time limit for PNDM has changed over the years, ranging from onset within 30 days of birth to 3 months of age. However, as patients with the clinical phenotype caused by mutation in the KCNJ11 gene have been identified with onset up to 6 months of age, Massa et al. (2005) suggested that the term 'permanent diabetes mellitus of infancy' (PDMI) replace PNDM Continue reading >>

Prematurity And Genetic Testing For Neonatal Diabetes

Prematurity And Genetic Testing For Neonatal Diabetes

Prematurity and Genetic Testing for Neonatal Diabetes Rachel E.J. Besser, Sarah E. Flanagan, Deborah G.J. Mackay, I.K. Temple, Maggie H. Shepherd, Beverley M. Shields, Sian Ellard, Andrew T. Hattersley BACKGROUND: Hyperglycemia in premature infants is usually thought to reflect inadequate pancreatic development rather than monogenic neonatal diabetes. No studies, to our knowledge, have investigated the prevalence of monogenic forms of diabetes in preterm infants. METHODS: We studied 750 patients with diabetes diagnosed before 6 months of age. We compared the genetic etiology and clinical characteristics of 146 preterm patients born <37 weeks and compared them with 604 born 37 weeks. RESULTS: A genetic etiology was found in 97/146 (66%) preterm infants compared with 501/604 (83%) born 37weeks, P < .0001. Chromosome 6q24 imprinting abnormalities (27% vs 12%, P = .0001) and GATA6 mutations (9% vs 2%, P = .003) occurred more commonly in preterm than term infants while mutations in KCNJ11 were less common (21 vs 34%, P = .008). Preterm patients with an identified mutation were diagnosed later than those without an identified mutation (median [interquartile range] 35 [34 to 36] weeks vs 31 [28 to 36] weeks, P < .0001). No difference was seen in other clinical characteristics of preterm patients with and without an identified mutation including age of presentation, birth weight, and time to referral. CONCLUSIONS: Patients with neonatal diabetes due to a monogenic etiology can be born preterm, especially those with 6q24 abnormalities or GATA6 mutations. A genetic etiology is more likely in patients with less severe prematurity (>32 weeks). Prematurity should not prevent referral for genetic testing as 37% have a potassium channel mutation and as a result can get improved contr Continue reading >>

Neonatal Diabetes - Other Types Of Diabetes Mellitus - Diapedia, The Living Textbook Of Diabetes

Neonatal Diabetes - Other Types Of Diabetes Mellitus - Diapedia, The Living Textbook Of Diabetes

Neonatal diabetes is diagnosed within the first 6 months of life and affects approximately 1 in 100,000 live births. The diabetes can occur in isolation or feature as part of a multi-organ disease (syndromic neonatal diabetes). Two main subgroups are recognised in about equal proportions: permanent neonatal diabetes (PNDM) and transient neonatal diabetes (TNDM). The latter remits in infancy or early childhood but may recur later in life. A genetic diagnosis is possible for approximately 80% of patients with neonatal diabetes with mutations in 22 different genes reported. Sporadic, dominant, recessive and X-linked inheritance have all been described. An early genetic diagnosis is clinically important since some forms involve the ATP-sensitive potassium (KATP) channel within the pancreatic beta cell and respond to treatment with high dose sulfonylureas which results in improved glycemic control for these patient. Mutations in 19 different genes have been reported to cause PNDM. These mutations cause diabetes through abnormal pancreatic development, beta cell dysfunction or accelerated beta cell destruction [1] . Patients typically have reduced birth weight, a reflection of reduced insulin production in utero, and whilst most are diagnosed with diabetes before 6 months a few rare cases have been reported with diabetes diagnosed between 6 and 12 months of life. In contrast to Type 1 diabetes PNDM is not associated with high risk HLA haplotypes or the presence of pancreatic autoantibodies. The most common cause of PNDM results from Mutations in the insulin gene (INS) or Mutations in the K-ATP channel genes (KCNJ11 and ABCC8) [2] . Whilst the majority of patients with K-ATP channel mutations have isolated diabetes, severe developmental delay and epilepsy (termed DEND syndrom Continue reading >>

The Key Features Of Neonatal Diabetes Are:

The Key Features Of Neonatal Diabetes Are:

Neonatal diabetes is a form of diabetes that is diagnosed under the age of nine months. It’s a different type of diabetes than the more common Type 1 diabetes as it’s not an autoimmune condition (where the body has destroyed its insulin producing cells). Neonatal diabetes is caused by a change in a gene which affects insulin production. This means that levels of blood glucose (sugar) in the body rise very high. The main feature of neonatal diabetes is being diagnosed with diabetes under the age of 6 months, and this is where it’s different from Type 1, as Type 1 doesn’t affect anyone under 6 months. As well as this, about 20 per cent of people with neonatal diabetes also have some developmental delay (eg muscle weakness, learning difficulties) and epilepsy. Neonatal diabetes is very rare, currently there are less than 100 people diagnosed with it in the UK. There are two types of neonatal diabetes – transient and permanent. As the name suggests, transient neonatal diabetes doesn’t last forever and usually resolves before the age of 12 months. But it usually recurs later on in life, generally during the teenage years. It accounts for 50–60 per cent of all cases. Permanent neonatal diabetes as you might expect, lasts forever and accounts for 40–50 per cent of all cases. Around 50 per cent of people with neonatal diabetes don’t need insulin and can be treated with a tablet called Glibenclamide instead. These people have a change in the KCNJ11 or ABCC8 gene and need higher doses of Glibenclamide than would be used to treat type 2 diabetes. As well as controlling blood glucose levels, Glibenclamide can also improve the symptoms of developmental delay. It’s important to know if you have/your child has neonatal diabetes to make sure you’re/they’re getti Continue reading >>

Monogenic Diabetes (neonatal Diabetes Mellitus & Mody)

Monogenic Diabetes (neonatal Diabetes Mellitus & Mody)

The most common forms of diabetes, type 1 and type 2, are polygenic, meaning they are related to a change, or defect, in multiple genes. Environmental factors, such as obesity in the case of type 2 diabetes, also play a part in the development of polygenic forms of diabetes. Polygenic forms of diabetes often run in families. Doctors diagnose polygenic forms of diabetes by testing blood glucose, also known as blood sugar, in individuals with risk factors or symptoms of diabetes. Genes provide the instructions for making proteins within the cell. If a gene has a change or mutation, the protein may not function properly. Genetic mutations that cause diabetes affect proteins that play a role in the ability of the body to produce insulin or in the ability of insulin to lower blood glucose. People typically have two copies of most genes, with one gene inherited from each parent. What are monogenic forms of diabetes? Some rare forms of diabetes result from mutations or changes in a single gene and are called monogenic. In the United States, monogenic forms of diabetes account for about 1 to 4 percent of all cases of diabetes.1,2,3,4 In most cases of monogenic diabetes, the gene mutation is inherited from one or both parents. Sometimes the gene mutation develops spontaneously, meaning that the mutation is not carried by either of the parents. Most mutations that cause monogenic diabetes reduce the body’s ability to produce insulin, a protein produced in the pancreas that helps the body use glucose for energy. Neonatal diabetes mellitus (NDM) and maturity-onset diabetes of the young (MODY) are the two main forms of monogenic diabetes. NDM occurs in newborns and young infants. MODY is much more common than NDM and usually first occurs in adolescence or early adulthood. Most cas Continue reading >>

Permanent Neonatal Diabetes Mellitus

Permanent Neonatal Diabetes Mellitus

Initial Posting: February 8, 2008; Last Update: July 29, 2016. Permanent neonatal diabetes mellitus (PNDM) is characterized by the onset of hyperglycemia within the first six months of life (mean age: 7 weeks; range: birth to 26 weeks). The diabetes mellitus is associated with partial or complete insulin deficiency. Clinical manifestations at the time of diagnosis include intrauterine growth retardation, hyperglycemia, glycosuria, osmotic polyuria, severe dehydration, and failure to thrive. Therapy with insulin corrects the hyperglycemia and results in dramatic catch-up growth. The course of PNDM varies by genotype . Persistent hyperglycemia (plasma glucose concentration >150-200 mg/dL) in infants younger than age six months establishes the diagnosis of PNDM. Molecular testing is recommended: identification of pathogenic variant (s) in ABCC8 or KCNJ11 can guide treatment. Treatment of manifestations: Start rehydration and intravenous insulin infusion promptly after diagnosis. When the infant is stable and tolerating oral feedings begin subcutaneous insulin therapy. Children with pathogenic variants in ABCC8 or KCNJ11 can be treated with oral sulfonylureas; all others require long-term insulin therapy. High caloric intake is necessary for appropriate weight gain. Pancreatic enzyme replacement therapy is required for those with exocrine pancreatic insufficiency. Prevention of secondary complications: Aggressive treatment and frequent monitoring of blood glucose concentrations to avoid acute complications such as diabetic ketoacidosis and hypoglycemia and reduce the long-term complications of diabetes mellitus. Surveillance: Lifelong monitoring of blood glucose concentrations at least four times a day; periodic developmental evaluations. After age ten years, annual screen Continue reading >>

Orphanet: Permanent Neonatal Diabetes Mellitus

Orphanet: Permanent Neonatal Diabetes Mellitus

Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. For all other comments, please send your remarks via contact us . Only comments written in English can be processed. Check this box if you wish to receive a copy of your message Permanent neonatal diabetes mellitus (PNDM) is a monogenic form of neonatal diabetes (NDM, see this term) characterized by persistent hyperglycemia within the first 12 months of life in general, requiring continuous insulin treatment. Inheritance: Autosomal dominantorAutosomal recessive Age of onset: Antenatal, Neonatal, Infancy The incidence of NDM is estimated to be 1/95,000 to 1/150,000 live births. About 50% of NDM cases are permanent (PNDM) and 50% transient (TNDM, see this term). The condition has been reported in all ethnic groups and affects male and female infants equally. The median age of onset of PNDM is nine weeks. Initial clinical manifestations include hyperglycemia, glycosuria, intrauterine growth retardation, osmotic polyuria, severe dehydration, and failure to gain weight. The subsequent course of the disease depends on the genetic defect underlying DM. Most patients display some degree of developmental coordination disorder (including visual-spatial dyspraxia). Manifestations depend on the type of gene mutation involved. In KCNJ11 and ABCC8-related cases, patients usually present before three months of age with symptomatic hyperglycemia, and often ketoacidosis. Approximately 25% of patients with mutations in the KCNJ11 gene have associated neurological findings, including developmental delay and epilepsy (DEND syndrome, see this term) or a milder form of DEND without seizures and with less severe developmental delay (intermediate DEND, see this term). In INS-related Continue reading >>

Neonatal Diabetes Mellitus: A Disease Linked To Multiple Mechanisms

Neonatal Diabetes Mellitus: A Disease Linked To Multiple Mechanisms

Abstract Transient (TNDM) and Permanent (PNDM) Neonatal Diabetes Mellitus are rare conditions occurring in 1:300,000–400,000 live births. TNDM infants develop diabetes in the first few weeks of life but go into remission in a few months, with possible relapse to a permanent diabetes state usually around adolescence or as adults. The pancreatic dysfunction in this condition may be maintained throughout life, with relapse initiated at times of metabolic stress such as puberty or pregnancy. In PNDM, insulin secretory failure occurs in the late fetal or early post-natal period and does not go into remission. Patients with TNDM are more likely to have intrauterine growth retardation and less likely to develop ketoacidosis than patients with PNDM. In TNDM, patients are younger at the diagnosis of diabetes and have lower initial insulin requirements. Considerable overlap occurs between the two groups, so that TNDM cannot be distinguished from PNDM based on clinical features. Very early onset diabetes mellitus seems to be unrelated to autoimmunity in most instances. A number of conditions are associated with PNDM, some of which have been elucidated at the molecular level. Among these, the very recently elucidated mutations in the KCNJ11 and ABCC8 genes, encoding the Kir6.2 and SUR1 subunit of the pancreatic KATP channel involved in regulation of insulin secretion, account for one third to half of the PNDM cases. Molecular analysis of chromosome 6 anomalies (found in more than 60% in TNDM), and the KCNJ11 and ABCC8 genes encoding Kir6.2 and SUR1, provides a tool to identify TNDM from PNDM in the neonatal period. This analysis also has potentially important therapeutic consequences leading to transfer some patients, those with mutations in KCNJ11 and ABCC8 genes, from insulin t Continue reading >>

Neonatal Diabetes Mellitus: A Genetic And Clinical Approach

Neonatal Diabetes Mellitus: A Genetic And Clinical Approach

Neonatal Diabetes Mellitus: A Genetic and Clinical Approach AM Xanthopoulou 1 # , E Xanthopoulou 2 # ,D Papazoglou 1 andN Papanas 1 * 1 Diabetes Centre, Second Departmentof Internal Medicine, Medical School,Democritus University of Thrace,Alexandroupolis, Greece 2 Department of Molecular Biology,Democritus University of Thrace,Alexandroupolis, Greece Diabetes Centre, Second Departmentof Internal Medicine Medical School,Democritus University of Thrace G. Kondyli22c, Alexandroupolis 68100, Greece. Received date: October 23, 2017; Accepted date: October 25, 2017; Published date: November 11, 2017 Citation: Xanthopoulou AM, XanthopoulouE, Papazoglou D, Papanas N. (2017) NeonatalDiabetes Mellitus: A Genetic and ClinicalApproach. J Mol Genet Med Vol.1 No.1:6 Visit for more related articles at Journal of Molecular Genetics and Medicine Insulin exerts a pivotal role in the glucose homeostasis ofthe human body, while its deficits are related to completeinadequacies, such as Type 1 diabetes mellitus or relateddeficiencies such as Type 2 diabetes mellitus [ 1 - 4 ]. It has beenidentified that these deficiencies have a genetic backgroundand can arise either from mutations in a single gene (monogenicforms of diabetes) or by a combination of rare genetic mutationsthe action of environmental factors (polygenic forms ofdiabetes) [ 4 - 7 ]. Although the exact aetiology of diabetes remainsunknown, it appears to follow a polygenic inheritance pattern,and it is believed that the genetic and environmental factorsassociated with it have the potential to affect its appearance anddevelopment in most cases [ 8 ]. However, monogenic forms have been observed during neonataland early infancy , resulting in the occurrence of permanentand transient neonatal diabetes mellitus [ 1 , 9 - 13 ]. The for Continue reading >>

Genetics And Pathophysiology Of Neonatal Diabetes Mellitus

Genetics And Pathophysiology Of Neonatal Diabetes Mellitus

Genetics and pathophysiology of neonatal diabetes mellitus We are experimenting with display styles that make it easier to read articles in PMC. The ePub format uses eBook readers, which have several "ease of reading" features already built in. The ePub format is best viewed in the iBooks reader. You may notice problems with the display of certain parts of an article in other eReaders. Generating an ePub file may take a long time, please be patient. Genetics and pathophysiology of neonatal diabetes mellitus Rochelle N Naylor, Siri Atma W Greeley, [...], and Louis H Philipson Neonatal diabetes mellitus (NDM) is the term commonly used to describe diabetes with onset before 6 monthsofage. It occurs in approximately one out of every 100,000300,000 live births. Although this term encompasses diabetes of any etiology, it is recognized that NDM diagnosed before 6 monthsofage is most often monogenic in nature. Clinically, NDM subgroups include transient (TNDM) and permanent NDM (PNDM), as well as syndromic cases of NDM. TNDM often develops within the first few weeks of life and remits by a few months of age. However, relapse occurs in 50% of cases, typically in adolescence or adulthood. TNDM is most frequently caused by abnormalities in the imprinted region of chromosome 6q24, leading to overexpression of paternally derived genes. Mutations in KCNJ11 and ABCC8, encoding the two subunits of the adenosine triphosphatesensitive potassium channel on the cell membrane, can cause TNDM, but more often result in PNDM. NDM as a result of mutations in KCNJ11 and ABCC8 often responds to sulfonylureas, allowing transition from insulin therapy. Mutations in other genes important to cell function and regulation, and in the insulin gene itself, also cause NDM. In 40% of NDM cases, the geneti Continue reading >>

Neonatal Diabetes | Monogenic Diabetes At University Of Chicago Kovler Diabetes Center

Neonatal Diabetes | Monogenic Diabetes At University Of Chicago Kovler Diabetes Center

Diabetes diagnosed in babies is quite rare. Diabetes diagnosed within the first 6 months of life is called neonatal diabetes mellitus. Neonatal diabetes may be permanent or temporary Babies diagnosed with diabetes often have a single gene cause (monogenic). Those diagnosed before 6 months of age, they have an 80% chance of that being linked to a DNA issue. For those diagnosed from 6 months to 1 year, that percentage decreases to about 5%. It can be They tend to be misdiagnosed with type 1 diabetes before being diagnosed with monogenic diabetes. Here at the University of Chicago, we include babies diagnosed less than 1 year of age in our studies. Diabetes is a chronic condition where the blood sugar remains high. There are many causes but typically the pancreas produces insufficient insulin. Insulin is a hormone needed to allow sugar (glucose) to enter cells to produce energy. People with monogenic diabetes may pass it on to children or future generations. Each gene has a different inheritance pattern. The most common neonatal diabetes genes are listed below Click on each to learn more Continue reading >>

Permanent Neonatal Diabetes Mellitus - Genetics Home Reference

Permanent Neonatal Diabetes Mellitus - Genetics Home Reference

Flanagan SE, Clauin S, Bellann-Chantelot C, de Lonlay P, Harries LW, Gloyn AL, Ellard S. Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism. Hum Mutat. 2009 Feb;30(2):170-80. doi: 10.1002/humu.20838. Review. Flanagan SE, Edghill EL, Gloyn AL, Ellard S, Hattersley AT. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia. 2006 Jun;49(6):1190-7. Epub 2006 Apr 12. Malecki MT, Mlynarski W. Monogenic diabetes: implications for therapy of rare types of disease. Diabetes Obes Metab. 2008 Aug;10(8):607-16. Epub 2007 May 6. Review. Osbak KK, Colclough K, Saint-Martin C, Beer NL, Bellann-Chantelot C, Ellard S, Gloyn AL. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat. 2009 Nov;30(11):1512-26. doi: 10.1002/humu.21110. Review. Polak M, Cav H. Neonatal diabetes mellitus: a disease linked to multiple mechanisms. Orphanet J Rare Dis. 2007 Mar 9;2:12. Review. Rubio-Cabezas O, Klupa T, Malecki MT; CEED3 Consortium. Permanent neonatal diabetes mellitus--the importance of diabetes differential diagnosis in neonates and infants. Eur J Clin Invest. 2011 Mar;41(3):323-33. doi: 10.1111/j.1365-2362.2010.02409.x. Epub 2010 Nov 4. Review. Sty J, Steiner DF, Park SY, Ye H, Philipson LH, Bell GI. Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene. Rev Endocr Metab Disord. 2010 Sep;11(3):205-15. doi: 10.1007/s11154-010-9151-3. Review. Erratum in: Rev Endocr Metab Disord. 2012 Mar;13(1):79-81. Continue reading >>

Permanent Neonatal Diabetes

Permanent Neonatal Diabetes

Permanent neonatal diabetes mellitus (PNDM) is diagnosed within the first six months of life and in contrast to Type 1 diabetes is not associated with high risk HLA haplotypes or the presence of pancreatic autoantibodies. The incidence of PNDM is estimated to be less than 1 in 200,000 live births and a genetic diagnosis is possible for approximately 60% of patients with mutations in 19 different genes reported. Patients with PNDM may have isolated diabetes or the diabetes may form part of a syndrome. A few patients have mutations in key pancreatic transcription factor genes involved in beta-cell development and/or function. These patients often present with specific extra-pancreatic features which reflect the expression profile of the transcription factor in various tissues. The most common cause of isolated PNDM results from mutations in the genes encoding insulin (INS) or the pancreatic ATP-sensitive potassium (K-ATP) channel subunits Kir6.2 and SUR1 (KCNJ11 or ABCC8). For all patients a genetic diagnosis is clinically important as it will provide information regarding recurrence risk and in some cases will lead to improved treatment regimens. Mutations in the KCNJ11 and ABCC8 genes are the most common cause of PNDM accounting for approximately 40% of all cases. All KCNJ11 mutations identified to date are heterozygous having either arisen de novo or inherited from an affected parent. In contrast, both de novo, dominantly inherited and more rarely recessively inherited mutations in the ABCC8 gene have been reported. Functional studies have demonstrated that these ABCC8 and KCNJ11 mutations cause diabetes by reducing the sensitivity of the K-ATP channel to ATP thereby preventing insulin secretion. Patients with K-ATP channel mutations typically have a low birth weight Continue reading >>

Neonatal Diabetes Mellitus

Neonatal Diabetes Mellitus

Neonatal Diabetes Mellitus (NDM) Neonatal Diabetes Mellitus (NDM) Neonatal diabetes mellitus (NDM) is defined as a disease that affects an infant and their body's ability to produce or use insulin.[1] NDM is a monogenic (controlled by a single gene) form of diabetes that occurs in the first 6 months of life. Infants do not produce enough insulin, leading to an increase in . It is a rare disease, occurring in only one in 100,000 to 500,000 live births.[2] NDM can be mistaken for the much more common type 1 diabetes, but type 1 diabetes usually occurs later than the first 6 months of life. There are two types of NDM: permanent neonatal diabetes mellitus (PNDM) is a lifelong condition. Transient neonatal diabetes mellitus (TNDM) is diabetes that disappears during the infant stage but may reappear later in life.[2] Specific genes that can cause NDM have been identified.[3] The onset of NDM can be caused by abnormal pancreatic development, beta cell dysfunction or accelerated beta cell dysfunction.[4] Individuals with monogenic diabetes can pass it on to their children or future generations. Each gene associated with NDM has a different inheritance pattern. Mechanism[edit] Transient Neonatal Diabetes Mellitus (TNDM)[edit] TNDM occurs within the first several days to weeks of an infant's life. Intrauterine growth restriction (IUGR) is commonly seen in affected individuals and defined as poor growth of an unborn baby while in his or her mother's womb.[5] In comparison, of PNDM, the insulin dose requirement of TNDM is often lower. TNDM resolves on its own at an average age of twelve weeks. Although, individuals will relapse in 50% of cases (usually during childhood or young adulthood).[6] The parts of the body that are mostly affected are the pancreas, central nervous system an Continue reading >>

Genetic Testing For Neonatal Diabetes

Genetic Testing For Neonatal Diabetes

Genetic testing for neonatal diabetes is provided free of charge through funding from the Wellcome Trust (until at least 2020). This applies to all patients with diabetes diagnosed before 9 months of age anywhere in the world and regardless of their current age. Before sending a sample, please complete the form belowelectronically and email it to [email protected] . This will allow us to pre-log the patient on our database and start the test as soon as the sample is received. Please include samples from both parents whenever possible whether affected or unaffected. Testing of parental samples is often key to obtain a genetic diagnosis since the majority of mutations causing neonatal diabetes are found to have arisen spontaneously in patients. Samples must be labelled with name and date of birth. Please send either 3-5 ml of blood (our preferred option) taken in tubes containing EDTA and transported fresh (not frozen) at room temperature to arrive in the UK within 5 days. Blood samples should be sent in leak-proof packaging and include absorbent material to absorb any leakage.OR Send 2-10 micrograms of DNA at room temperature. Again please make sure the tube is very securely sealed. Additional DNA will help us to test for further causes of neonatal diabetes. The samples and a printed copy of the neonatal diabetes request form (link) should be sent to: Prof Sian Ellard, Department of Molecular Genetics, RILD Level 3, Royal Devon and Exeter NHS Foundation Trust, Barrack Road, Exeter, EX2 5DW, UK When the samples are delivered to the Exeter laboratory, you will receive an automated email confirming samples receipt. The samples will be first tested for the most common causes of neonatal diabetes (mutations in the ABCC8, KCNJ11 , and INS genes) by Sanger sequencing, u Continue reading >>

More in diabetes